Your payment is in progress...

Global Liposome Drug Delivery Market Growth 2020-2025

Published on: Sep 2020 | From USD $3660 | Published By: LP INFORMATION INC. | Number Of Pages: 160

According to this study, over the next five years the Liposome Drug Delivery market will register a 13.3%% CAGR in terms of revenue, the global market size will reach $ 5397.1 million by 2025, from $ 3277.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Liposome Drug Delivery business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Drug Delivery market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Liposome Drug Delivery, covering the supply chain analysis, impact assessment to the Liposome Drug Delivery market size growth rate in several scenarios, and the measures to be undertaken by Liposome Drug Delivery companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Fungal Infection Therapy
Cancer & Tumor Therapy
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Gilead Sciences
Novartis
Pacira
Johnson & Johnson
Luye Pharma
Sun Pharmaceutical
CSPC
Sigma-Tau
Teva Pharmaceutical
Ipsen (Onivyde)
Fudan-Zhangjiang

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Liposome Drug Delivery consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Liposome Drug Delivery market by identifying its various subsegments.
Focuses on the key global Liposome Drug Delivery manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Liposome Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Liposome Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposome Drug Delivery Consumption 2015-2025
2.1.2 Liposome Drug Delivery Consumption CAGR by Region
2.2 Liposome Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposome Drug Delivery Consumption by Type
2.3.1 Global Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
2.3.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2015-2020)
2.3.3 Global Liposome Drug Delivery Sale Price by Type (2015-2020)
2.4 Liposome Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposome Drug Delivery Consumption by Application
2.5.1 Global Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
2.5.2 Global Liposome Drug Delivery Value and Market Share by Type (2015-2020)
2.5.3 Global Liposome Drug Delivery Sale Price by Type (2015-2020)

3 Global Liposome Drug Delivery by Company
3.1 Global Liposome Drug Delivery Sales Market Share by Company
3.1.1 Global Liposome Drug Delivery Sales by Company (2018-2020)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Company (2018-2020)
3.2 Global Liposome Drug Delivery Revenue Market Share by Company
3.2.1 Global Liposome Drug Delivery Revenue by Company (2018-2020)
3.2.2 Global Liposome Drug Delivery Revenue Market Share by Company (2018-2020)
3.3 Global Liposome Drug Delivery Sale Price by Company
3.4 Global Liposome Drug Delivery Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Liposome Drug Delivery Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Liposome Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Liposome Drug Delivery by Regions
4.1 Liposome Drug Delivery by Regions
4.2 Americas Liposome Drug Delivery Consumption Growth
4.3 APAC Liposome Drug Delivery Consumption Growth
4.4 Europe Liposome Drug Delivery Consumption Growth
4.5 Middle East & Africa Liposome Drug Delivery Consumption Growth

5 Americas
5.1 Americas Liposome Drug Delivery Consumption by Countries
5.1.1 Americas Liposome Drug Delivery Consumption by Countries (2015-2020)
5.1.2 Americas Liposome Drug Delivery Value by Countries (2015-2020)
5.2 Americas Liposome Drug Delivery Consumption by Type
5.3 Americas Liposome Drug Delivery Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Liposome Drug Delivery Consumption by Regions
6.1.1 APAC Liposome Drug Delivery Consumption by Regions (2015-2020)
6.1.2 APAC Liposome Drug Delivery Value by Regions (2015-2020)
6.2 APAC Liposome Drug Delivery Consumption by Type
6.3 APAC Liposome Drug Delivery Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Liposome Drug Delivery by Countries
7.1.1 Europe Liposome Drug Delivery Consumption by Countries (2015-2020)
7.1.2 Europe Liposome Drug Delivery Value by Countries (2015-2020)
7.2 Europe Liposome Drug Delivery Consumption by Type
7.3 Europe Liposome Drug Delivery Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Liposome Drug Delivery by Countries
8.1.1 Middle East & Africa Liposome Drug Delivery Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Liposome Drug Delivery Value by Countries (2015-2020)
8.2 Middle East & Africa Liposome Drug Delivery Consumption by Type
8.3 Middle East & Africa Liposome Drug Delivery Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Liposome Drug Delivery Distributors
10.3 Liposome Drug Delivery Customer

11 Global Liposome Drug Delivery Market Forecast
11.1 Global Liposome Drug Delivery Consumption Forecast (2021-2025)
11.2 Global Liposome Drug Delivery Forecast by Regions
11.2.1 Global Liposome Drug Delivery Forecast by Regions (2021-2025)
11.2.2 Global Liposome Drug Delivery Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Liposome Drug Delivery Forecast by Type
11.8 Global Liposome Drug Delivery Forecast by Application

12 Key Players Analysis
12.1 Gilead Sciences
12.1.1 Company Information
12.1.2 Liposome Drug Delivery Product Offered
12.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Gilead Sciences Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 Liposome Drug Delivery Product Offered
12.2.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Pacira
12.3.1 Company Information
12.3.2 Liposome Drug Delivery Product Offered
12.3.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pacira Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Liposome Drug Delivery Product Offered
12.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Luye Pharma
12.5.1 Company Information
12.5.2 Liposome Drug Delivery Product Offered
12.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Luye Pharma Latest Developments
12.6 Sun Pharmaceutical
12.6.1 Company Information
12.6.2 Liposome Drug Delivery Product Offered
12.6.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sun Pharmaceutical Latest Developments
12.7 CSPC
12.7.1 Company Information
12.7.2 Liposome Drug Delivery Product Offered
12.7.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CSPC Latest Developments
12.8 Sigma-Tau
12.8.1 Company Information
12.8.2 Liposome Drug Delivery Product Offered
12.8.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sigma-Tau Latest Developments
12.9 Teva Pharmaceutical
12.9.1 Company Information
12.9.2 Liposome Drug Delivery Product Offered
12.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Teva Pharmaceutical Latest Developments
12.10 Ipsen (Onivyde)
12.10.1 Company Information
12.10.2 Liposome Drug Delivery Product Offered
12.10.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Ipsen (Onivyde) Latest Developments
12.11 Fudan-Zhangjiang
12.11.1 Company Information
12.11.2 Liposome Drug Delivery Product Offered
12.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Fudan-Zhangjiang Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Liposome Drug Delivery Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Liposomal Doxorubicin
Table 5. Major Players of Liposomal Amphoteracin B
Table 6. Major Players of Liposomal Paclitaxel
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
Table 10. Global Liposome Drug Delivery Revenue by Type (2015-2020) ($ million)
Table 11. Global Liposome Drug Delivery Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Liposome Drug Delivery Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Liposome Drug Delivery Consumption Market Share by Application (2015-2020)
Table 15. Global Liposome Drug Delivery Value by Application (2015-2020)
Table 16. Global Liposome Drug Delivery Value Market Share by Application (2015-2020)
Table 17. Global Liposome Drug Delivery Sale Price by Application (2015-2020)
Table 18. Global Liposome Drug Delivery Sales by Company (2017-2019) (K Vial)
Table 19. Global Liposome Drug Delivery Sales Market Share by Company (2017-2019)
Table 20. Global Liposome Drug Delivery Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Liposome Drug Delivery Revenue Market Share by Company (2017-2019)
Table 22. Global Liposome Drug Delivery Sale Price by Company (2017-2019)
Table 23. Global Liposome Drug Delivery Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Liposome Drug Delivery Products Offered
Table 25. Liposome Drug Delivery Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Liposome Drug Delivery Consumption by Regions 2015-2020 (K Vial)
Table 27. Global Liposome Drug Delivery Consumption Market Share by Regions 2015-2020
Table 28. Global Liposome Drug Delivery Value by Regions 2015-2020 ($ Millions)
Table 29. Global Liposome Drug Delivery Value Market Share by Regions 2015-2020
Table 30. Americas Liposome Drug Delivery Consumption by Countries (2015-2020) (K Vial)
Table 31. Americas Liposome Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 32. Americas Liposome Drug Delivery Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Liposome Drug Delivery Value Market Share by Countries (2015-2020)
Table 34. Americas Liposome Drug Delivery Consumption by Type (2015-2020) (K Vial)
Table 35. Americas Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
Table 36. Americas Liposome Drug Delivery Consumption by Application (2015-2020) (K Vial)
Table 37. Americas Liposome Drug Delivery Consumption Market Share by Application (2015-2020)
Table 38. APAC Liposome Drug Delivery Consumption by Countries (2015-2020) (K Vial)
Table 39. APAC Liposome Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 40. APAC Liposome Drug Delivery Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Liposome Drug Delivery Value Market Share by Regions (2015-2020)
Table 42. APAC Liposome Drug Delivery Consumption by Type (2015-2020) (K Vial)
Table 43. APAC Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
Table 44. APAC Liposome Drug Delivery Consumption by Application (2015-2020) (K Vial)
Table 45. APAC Liposome Drug Delivery Consumption Market Share by Application (2015-2020)
Table 46. Europe Liposome Drug Delivery Consumption by Countries (2015-2020) (K Vial)
Table 47. Europe Liposome Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 48. Europe Liposome Drug Delivery Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Liposome Drug Delivery Value Market Share by Countries (2015-2020)
Table 50. Europe Liposome Drug Delivery Consumption by Type (2015-2020) (K Vial)
Table 51. Europe Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
Table 52. Europe Liposome Drug Delivery Consumption by Application (2015-2020) (K Vial)
Table 53. Europe Liposome Drug Delivery Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Liposome Drug Delivery Consumption by Countries (2015-2020) (K Vial)
Table 55. Middle East & Africa Liposome Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Liposome Drug Delivery Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Liposome Drug Delivery Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Liposome Drug Delivery Consumption by Type (2015-2020) (K Vial)
Table 59. Middle East & Africa Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Liposome Drug Delivery Consumption by Application (2015-2020) (K Vial)
Table 61. Middle East & Africa Liposome Drug Delivery Consumption Market Share by Application (2015-2020)
Table 62. Liposome Drug Delivery Distributors List
Table 63. Liposome Drug Delivery Customer List
Table 64. Global Liposome Drug Delivery Consumption Forecast by Countries (2021-2025) (K Vial)
Table 65. Global Liposome Drug Delivery Consumption Market Forecast by Regions
Table 66. Global Liposome Drug Delivery Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Liposome Drug Delivery Value Market Share Forecast by Regions
Table 68. Global Liposome Drug Delivery Consumption Forecast by Type (2021-2025) (K Vial)
Table 69. Global Liposome Drug Delivery Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Liposome Drug Delivery Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Liposome Drug Delivery Value Market Share Forecast by Type (2021-2025)
Table 72. Global Liposome Drug Delivery Consumption Forecast by Application (2021-2025) (K Vial)
Table 73. Global Liposome Drug Delivery Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Liposome Drug Delivery Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Liposome Drug Delivery Value Market Share Forecast by Application (2021-2025)
Table 76. Gilead Sciences Product Offered
Table 77. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 78. Gilead Sciences Main Business
Table 79. Gilead Sciences Latest Developments
Table 80. Gilead Sciences Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Product Offered
Table 82. Novartis Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Novartis Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 86. Pacira Product Offered
Table 87. Pacira Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 88. Pacira Main Business
Table 89. Pacira Latest Developments
Table 90. Pacira Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Product Offered
Table 92. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 96. Luye Pharma Product Offered
Table 97. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 98. Luye Pharma Main Business
Table 99. Luye Pharma Latest Developments
Table 100. Luye Pharma Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 101. Sun Pharmaceutical Product Offered
Table 102. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 103. Sun Pharmaceutical Main Business
Table 104. Sun Pharmaceutical Latest Developments
Table 105. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 106. CSPC Product Offered
Table 107. CSPC Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 108. CSPC Main Business
Table 109. CSPC Latest Developments
Table 110. CSPC Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 111. Sigma-Tau Product Offered
Table 112. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 113. Sigma-Tau Main Business
Table 114. Sigma-Tau Latest Developments
Table 115. Sigma-Tau Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 116. Teva Pharmaceutical Product Offered
Table 117. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 118. Teva Pharmaceutical Main Business
Table 119. Teva Pharmaceutical Latest Developments
Table 120. Teva Pharmaceutical Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 121. Ipsen (Onivyde) Product Offered
Table 122. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 123. Ipsen (Onivyde) Main Business
Table 124. Ipsen (Onivyde) Latest Developments
Table 125. Ipsen (Onivyde) Basic Information, Company Total Revenue (in $ million), Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 126. Fudan-Zhangjiang Product Offered
Table 127. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 128. Fudan-Zhangjiang Main Business
Table 129. Fudan-Zhangjiang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Fudan-Zhangjiang Latest Developments
List of Figures
Figure 1. Picture of Liposome Drug Delivery
Figure 2. Liposome Drug Delivery Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Liposome Drug Delivery Consumption Growth Rate 2015-2025 (K Vial)
Figure 5. Global Liposome Drug Delivery Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Liposomal Doxorubicin
Figure 7. Product Picture of Liposomal Amphoteracin B
Figure 8. Product Picture of Liposomal Paclitaxel
Figure 9. Product Picture of Others
Figure 10. Global Liposome Drug Delivery Consumption Market Share by Type (2015-2020)
Figure 11. Global Liposome Drug Delivery Value Market Share by Type (2015-2020)
Figure 12. Liposome Drug Delivery Consumed in Fungal Infection Therapy
Figure 13. Global Liposome Drug Delivery Market: Fungal Infection Therapy (2015-2020) (K Vial)
Figure 14. Global Liposome Drug Delivery Market: Fungal Infection Therapy (2015-2020) ($ Millions)
Figure 15. Liposome Drug Delivery Consumed in Cancer & Tumor Therapy
Figure 16. Global Liposome Drug Delivery Market: Cancer & Tumor Therapy (2015-2020) (K Vial)
Figure 17. Global Liposome Drug Delivery Market: Cancer & Tumor Therapy (2015-2020) ($ Millions)
Figure 18. Liposome Drug Delivery Consumed in Others
Figure 19. Global Liposome Drug Delivery Market: Others (2015-2020) (K Vial)
Figure 20. Global Liposome Drug Delivery Market: Others (2015-2020) ($ Millions)
Figure 21. Global Liposome Drug Delivery Consumption Market Share by Application (2015-2020)
Figure 22. Global Liposome Drug Delivery Value Market Share by Application (2015-2020)
Figure 23. Global Liposome Drug Delivery Sales Market Share by Company in 2017
Figure 24. Global Liposome Drug Delivery Sales Market Share by Company in 2019
Figure 25. Global Liposome Drug Delivery Revenue Market Share by Company in 2017
Figure 26. Global Liposome Drug Delivery Revenue Market Share by Company in 2019
Figure 27. Global Liposome Drug Delivery Sale Price by Company in 2019
Figure 28. Global Liposome Drug Delivery Consumption Market Share by Regions 2015-2020
Figure 29. Global Liposome Drug Delivery Value Market Share by Regions 2015-2020
Figure 30. Americas Liposome Drug Delivery Consumption 2015-2020 (K Vial)
Figure 31. Americas Liposome Drug Delivery Value 2015-2020 ($ Millions)
Figure 32. APAC Liposome Drug Delivery Consumption 2015-2020 (K Vial)
Figure 33. APAC Liposome Drug Delivery Value 2015-2020 ($ Millions)
Figure 34. Europe Liposome Drug Delivery Consumption 2015-2020 (K Vial)
Figure 35. Europe Liposome Drug Delivery Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Liposome Drug Delivery Consumption 2015-2020 (K Vial)
Figure 37. Middle East & Africa Liposome Drug Delivery Value 2015-2020 ($ Millions)
Figure 38. Americas Liposome Drug Delivery Consumption Market Share by Countries in 2019
Figure 39. Americas Liposome Drug Delivery Value Market Share by Countries in 2019
Figure 40. Americas Liposome Drug Delivery Consumption Market Share by Type in 2019
Figure 41. Americas Liposome Drug Delivery Consumption Market Share by Application in 2019
Figure 42. United States Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 43. United States Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 45. Canada Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 47. Mexico Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Liposome Drug Delivery Consumption Market Share by Countries in 2019
Figure 49. APAC Liposome Drug Delivery Value Market Share by Regions in 2019
Figure 50. APAC Liposome Drug Delivery Consumption Market Share by Type in 2019
Figure 51. APAC Liposome Drug Delivery Consumption Market Share by Application in 2019
Figure 52. China Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 53. China Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 55. Japan Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 57. Korea Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 59. Southeast Asia Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 60. India Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 61. India Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 63. Australia Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Liposome Drug Delivery Consumption Market Share by Countries in 2019
Figure 65. Europe Liposome Drug Delivery Value Market Share by Countries in 2019
Figure 66. Europe Liposome Drug Delivery Consumption Market Share by Type in 2019
Figure 67. Europe Liposome Drug Delivery Consumption Market Share by Application in 2019
Figure 68. Germany Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 69. Germany Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 70. France Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 71. France Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 72. UK Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 73. UK Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 75. Italy Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 77. Russia Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Liposome Drug Delivery Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Liposome Drug Delivery Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Liposome Drug Delivery Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Liposome Drug Delivery Consumption Market Share by Application in 2019
Figure 82. Egypt Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 83. Egypt Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 85. South Africa Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 87. Israel Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 89. Turkey Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Liposome Drug Delivery Consumption Growth 2015-2020 (K Vial)
Figure 91. GCC Countries Liposome Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 92. Global Liposome Drug Delivery Consumption Growth Rate Forecast (2021-2025) (K Vial)
Figure 93. Global Liposome Drug Delivery Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 95. Americas Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 96. APAC Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 97. APAC Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 98. Europe Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 99. Europe Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 101. Middle East & Africa Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 102. United States Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 103. United States Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 104. Canada Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 105. Canada Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 106. Mexico Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 107. Mexico Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 108. Brazil Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 109. Brazil Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 110. China Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 111. China Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 112. Japan Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 113. Japan Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 114. Korea Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 115. Korea Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 117. Southeast Asia Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 118. India Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 119. India Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 120. Australia Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 121. Australia Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 122. Germany Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 123. Germany Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 124. France Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 125. France Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 126. UK Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 127. UK Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 128. Italy Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 129. Italy Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 130. Russia Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 131. Russia Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 132. Spain Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 133. Spain Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 134. Egypt Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 135. Egypt Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 136. South Africa Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 137. South Africa Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 138. Israel Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 139. Israel Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 140. Turkey Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 141. Turkey Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Liposome Drug Delivery Consumption 2021-2025 (K Vial)
Figure 143. GCC Countries Liposome Drug Delivery Value 2021-2025 ($ Millions)
Figure 144. Gilead Sciences Liposome Drug Delivery Market Share (2018-2020)
Figure 145. Novartis Liposome Drug Delivery Market Share (2018-2020)
Figure 146. Pacira Liposome Drug Delivery Market Share (2018-2020)
Figure 147. Johnson & Johnson Liposome Drug Delivery Market Share (2018-2020)
Figure 148. Luye Pharma Liposome Drug Delivery Market Share (2018-2020)
Figure 149. Sun Pharmaceutical Liposome Drug Delivery Market Share (2018-2020)
Figure 150. CSPC Liposome Drug Delivery Market Share (2018-2020)
Figure 151. Sigma-Tau Liposome Drug Delivery Market Share (2018-2020)
Figure 152. Teva Pharmaceutical Liposome Drug Delivery Market Share (2018-2020)
Figure 153. Ipsen (Onivyde) Liposome Drug Delivery Market Share (2018-2020)
Figure 154. Fudan-Zhangjiang Liposome Drug Delivery Market Share (2018-2020)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

FAQs

Market research is a defined process to collect information about customers, competitors, and everything that a business needs to understand to sustain and grow. It offers important analysis to distinguish and examine the market needs, size, and trends. Market research is generally divided into, primary research and/or secondary research.

The process usually includes collection and interpretation of market data by using statistical and analytical techniques to support the decision making process.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Market research reports provide in-depth analysis about the market conditions and requirements for effective decision making.
The report provides a snapshot of the global market size, segmentation data, marketing growth strategies, market share, export and import information, analysis and forecast of market trends, competition, domestic production, best sales prospects, statistical data, tariffs, regulations, distribution and business practices, end-user analysis, contact points and more.

These research reports include information about competitive strategies, solutions, fact-based research, key takeaways, recommendations, market considerations, emerging business models and market opportunities for multiple segments of an industry.

Market research reports assist in solving business problems and making better decisions to improve business as per the prevalent market trends.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website). There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Any person who has the capacity to make decisions for the business must buy the reports. These reports help management in decision making process. Market research helps person to obtain market information from different sources, and in multiple formats. It aims to study supply and demand, analyze data as per geography, age factors, demography, technology, product, psychographic & gender differences, and many other parameters. Access to in-depth market trends helps person to assess the market effectiveness. Some of the multiple techniques used for market research include customer analysis, choice modeling, competition and risk analysis, product research, advertising the research, marketing mix modeling, simulated test marketing, and more.
Market research studies several features of business environment, such as competitors, market structure, government regulations, economic trends, technological advances and financial analysis of companies, industries, and sectors. This helps person in the decision-making process of planning and implementing strategies for their markets.

The generation of research report is concerned by most clients when purchasing it. Following general steps are taken for generating reports.
1. Choose a topic.
2. Make skeleton catalogue.
3. Fill content. As for report content, there are two main information source, Primary and Secondary data collection. Secondary data collectionrefers to information searched from the Internet or data bought from database. Primary data collection refers to information concluded from telephone interview, face-to-face interview, expert’s interview, meeting etc.
4. Audit the report
5. Publish the report.

With regard to information cost, information searching costs the least, database support the second least, and telephone interview the third least. Face-face interview cost higher, in-depth interview much higher and expert interview the highest. A research may adopt all of these approaches, or just some of them.
In general, a good-quality research report needs 1-3 months to be finished. Time and method varies according to different Publishers. Thus, it’s difficult to define an exact procedure or process of making research report. Both time and cost vary. However, specialization has become a basic industry standard. Professional and dedicated products will be more and more popular.
MarketInsightsReports has focused on various fields such as Life Science, IT, Telecommunication, Food& Beverages, Energy & Power, Automotive & Transportation, Materials& Chemicals, Financial Services and many more. These market research reports are available for all regions around the globe.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website).

There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Please Choose License Type

USD $3660
USD $5490
USD $7320
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Recognised publishing sources Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Customer Support Customer Support
    Complete pre and post sales support.
  • Safe & Secure Safe & Secure
    Complete secure payment process.